Download hospital appointments

TERENCE TROW, MD, FACP, FCCP
CURRICULUM VITAE
Yale University School of Medicine
Department of Internal Medicine
Division of Pulmonary and Critical Care
333 Cedar Street, P.O. Box 208057
New Haven, CT 06520-8057
Phone: 203-785-4196
Fax: 203-785-3634
Email: [email protected]
PERSONAL DATA:
Born:
Citizenship:
Marrital Status:
January 25, 1960, Exeter, New Hampshire
United States
Married to Catherine Ann Trow; son Colby.
EDUCATION:
MD
Dartmouth Medical School
Hanover, New Hampshire
Alpha omega alpha
BA
Bowdoin College
Brunswick, Maine
8/1982-6/1986
8/1979-5/1982
A.B. in Biochemistry with Highest Honors
Summa cum laude
Phi beta kappa
POST DOCTORAL TRAINING:
Yale University School of Medicine
Fellow in Pulmonary Medicine & Critical Care
7/1990-7/1993
Yale New Haven Hospital
New Haven, Connecticut
Cornell University Medical College
Resident in Internal Medicine,
7/1987-6/1989
New York Hospital,
New York, New York
University of Pennsylvania
Intern in Internal Medicine,
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
6/1986-6/1987
2
BOARD CERTIFIED:
American Board of Internal Medicine
American Board of Pulmonary Diseases
American Board of Critical Care Medicine
9/13/1989
11/1992, 2002 (recert),2012 (re-cert)
11/1993, 2003 (re-cert),
2013(re-cert)
LICENSED TO PRACTICE IN:
New York (inactive)
Connecticut (active)
LANGUAGE PROFICIENCY:
Fluent in conversational and written Spanish.
ACADEMIC APPOINTMENTS:
Associate Professor of Medicine
Yale University School of Medicine
5/2011-present
Assistant Professor of Medicine
Yale University School of Medicine
7/2005 – 5/2011
Assistant Clinical Professor of Medicine
SUNY at Stony Brook
9/2002-6/2005
Assistant Clinical Professor of Medicine
Yale University School of Medicine
7/1993-9/2002
HOSPITAL APPOINTMENTS:
Yale-New Haven Hospital
Director, Pulmonary Vascular Disease Program
8/01/05-present
Co-Director, Yale Winchester Chest Clinic
Assistant Professor of Medicine
New Haven, CT
8/06-9/12
Medical Director of Pulmonary Hypertension Center
Assistant Professor of Medicine, SUNY @ Stony Brook
Winthrop-University Hospital, Mineola, NY
Director of Respiratory Therapy & Interventional Pulmonary Services
Danbury Hospital, Danbury, CT
9/2002-6/2005
7/1993-8/2002
3
Junior Assistant Professor of Medicine
Columbia University College of Physicians & Surgeons
St. Luke’s/Roosevelt Hospital Center, New York, NY
7/1989-6/1990
COMMITTEES:
Appointed to American College of Chest Physicians Evidenced-Based Guidelines for the Diagnosis and Management
of Pulmonary Arterial Hypertension Committee, 2012-present.
Scientific Leadership Council of the Pulmonary Hypertension Association, 2011-present
Yale Medical Group, Credentialing Committee, 2011-present
Winchester Chest Clinic Advisory Committee, Yale University School of Medicine, Section of Critical Care and
Pulmonary Medicine, 2008-2011
Yale New-Haven Hospital Clinical Development Team, 2008-2011
Intern Selection Committee, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
2007-2012.
Yale New Haven Hospital Endoscopy/Bronchoscopy Suite Planning Steering Committee, New Haven, CT, 20072009.
Steering Committee, Pulmonary Hypertension Association National Continuing Medical Education Program, 20072009
Member, Internal Medicine Clinical Advisory Committee; 2007-2009.
Member, Yale New Haven Hospital Pharmacy and Therapeutics Committee; 2006-present
Chairman, SEP Pulmonary Board Review Course
American College of Chest Physicians International Conference
Chicago, IL, October 21, 2007
Chairman, SEP Pulmonary Board Review Course
American College of Chest Physicians International Conference
Salt Lake City, Utah, October 21, 2006
Pulmonary Vascular Disease Network Steering Committee; American College of Chest Physicians (2006-2013)
Vice-Chairman, SEP Pulmonary Board Review Course,
American College of Chest Physicians International Conference,
Montreal, Canada, October 30, 2005.
Co-Chairman, Clinical Year in Review- ATS International Conference (2004-2006)
Faculty Member, American Board of Internal Medicine (ABIM) Pulmonary Disease Self-Evaluation Process (SEP)
Course
American College of Chest Physicians International Annual Meeting, Seattle,
Washington, October 24, 2004
4
Standard Sub-Committee/Primary Stroke Center Committee-Winthrop University Hospital (2004-2005)
Maternal & Child Health Mortality Review Committee-Winthrop University Hospital (2004-2005)
Chairman, Cardiac Arrest Code QI Committee, Winthrop-University Hospital (2004-2005)
IPRO Smoking Cessation Committee-Winthrop University Hospital (2004-2005)
Thoracic Tumor Board Committee-Winthrop University Hospital (2003-2005)
Hospital Wide Critical Care QI Committee-Winthrop University Hospital (2002-2005)
House Staff Selection Committee-Winthrop University Hospital (2002-2005)
Critical Care QI Committee-Winthrop University Hospital (2002-2005)
Institutional Review Board-Winthrop University Hospital (2002-2005)
Preceptor for the Third Year Medical Students at SUNY @Stony Brook Medicine Clerkship (2002-2005)
Ad-Hoc Committee Leader for Re-evaluation of Outpatient Business Practice-Danbury Hospital (2000-2002)
Lung Tumor Board-Danbury Hospital (1999-2002)
Southbury Training School for the Developmentally Disabled Advisory Board (1996-1997)
Pulmonary Liaison for Stem Cell Transplant Program, Danbury Hospital (1994-2002)
Respiratory Therapy Work Re-Design Committee-Danbury Hospital (1994-1996)
Resident Evaluation Committee of Internal Medicine Residency Training Program-Danbury Hospital (1993-2002)
Critical Care QI Committee-Danbury Hospital (1993-2002)
Joint Practice ICU Committee-Danbury Hospital (1993-2002)
Ethics Committee-Danbury Hospital (1993-2002)
House Staff Selection Committee, Internal Medicine Residency Training Program-Danbury (1993-2002)
Director, Western Connecticut Pulmonary Conference (1993-2002)
Director, Pulmonary Board Review Course-Danbury Hospital (1993-2002)
ACADEMIC/PROFESSIONAL HONORS:
US News Top Doctor Award, 2012
Appointed to American College of Chest Physicians Evidenced-Based Guidelines for the Diagnosis and Management
of Pulmonary Arterial Hypertension Committee, 2012-present.
Appointed to the Scientific Leadership Council of the Pulmonary Hypertension Association, 2011-present.
Elected Governor of CT state chapter of the American College of Chest Physicians US and Canadian Council of
Govenors;2010-2012
Steering Committee, National Scleroderma Foundation National Echo Campaign, 2008-2013.
Steering Committee, National Pulmonary Hypertension Association Continuing Medical Education Program (20072009)
Steering Committee, Post Doctoral Fellows Program in Pulmonary Arterial Hypertension (2006)
Co-Chairman, Clinical Year in Review- American Thoracic Society International Conference (2004-2006)
Chair, Pulmonary Board SEP Review Course, American College of Physicians, 2006-2008
Vice-Chair, Pulmonary Board SEP Review Course, American College of Chest Physicians, 2005
Attending of the Year Award-Winthrop University Hospital (2003)
American Medical Association Physician’s Recognition Award (2000-2003)
Attending of the Year Award-Danbury Hospital (1994)
Phi beta kappa
Alpha omega alpha
5
PROFESSIONAL/SCIENTIFIC SOCIETIES:
American College of Chest Physicians-Fellow
American College of Physicians-Fellow
American Thoracic Society-Member
Connecticut Thoracic Society-Member, Executive Council (1994-2002) [Vice President}
Connecticut Thoracic Society- Member, 2006-present
Society for Critical Care Medicine-Member, 1993-1999
Pulmonary Hypertension Association (2004 – Present)
Pulmonary Hypertension Clinicians and Researcher, Pulmonary Hypertension Association (2005-present)
Who’s Who in American Medicine-Lifetime Member
REVIEWER AND EDITORIAL BOARD APPOINTMENTS:
American College of Chest Physicians Chest Journal, invited reviewer 1999-present
Clinical Pulmonary Medicine, Associate Editor - Pulmonary Trends, 2002-2005
Editorial Board, Proceedings of the American Thoracic Society, 2005-2013
Deputy Editor, Proceedings of the American Thoracic Society, 2009-2013.
American Journal of Respiratory and Critical Care Medicine, invited reviewer, 2005-present
Abstract Grader, American College of Chest Physicians International Conference, 2006-present
Current Medical Literature Respiratory Medicine, invited reviewer, 2006-present.
Annals of Internal Medicine, invited reviewer, 2007-present.
Southern Medical Journal, invited reviewer, 2007-present.
Heart and Lung, invited reviewer, 2007-present
Journal of Respiratory Diseases, invited reviewer, 2007-present.
Drug Design, Development and Therapy, invited reviewer, 2008-present.
Thorax, invited reviewer, 2008-present.
Future Cardiology, invited reviewer, 2009-present.
Hospital Practice; invited reviewer, 2011- present
Lung; invited reviewer, 2011-present
PLoS ; invited revewer, 2012-present
Editorial Board, Journal of Heart and Circulation, 2013-present.
Respiratory Care; invited reviewer 2013-present.
Annals of the American Thoracic Society Reviewer, 2013-present
Hospital Practice, 2014-present
SEMINARS AND LECTURES:
Inhaled, Infused and Oral Prostanoid Therapy in the Management of Pulmonary Arterial Hypertension, 8 th
Annual Yale Pulmonary Hypertension Symposium, Middletown, CT, June 5th, 2014.
“Current and Future Therapies of Pulmonary Arterial Hypertension”, Surgical House staff ICU Noon Lecture Series,
Yale University School of Medicine, New Haven, CT, April 22, 2014.
“Precious Body Fluids: Transport of Oxygen and Carbon Dioxide”, Respiratory Physiology Series, Yale Physician
Associates Program, New Haven, CT, March 18th, 2014
“Asthma, DVT/PE, Cough”, Yale University School of Medicine 2 nd Year Medical Student Workshops, New Haven,
CT, February 26th, 2014.
6
“Neuromuscular Disease, Acid-Base Disorders, and Epiglottitis”, Yale University 2nd Year Medical Student
Workshops, New Haven, CT, February 27th, 2014
“Pregnancy and Pulmonary Hypertension-The Perfect Storm”, American College of Physicians International
Conference, Chicago, IL, October 26, 2013.
“Pulmonary Arterial Hypertension Update”, American College of Physicians International Conference, Chicago, IL
October 27th, 2013.
“Current and Future Therapies in the Management of Pulmonary Arterial Hypertension”, Dr. Arthur Kotch Memorial
Lecture, Medical Grand Rounds, Danbury Hospital, Danbury, CT, October 2 nd, 2013.
“Current and Future Therapies in the Management of Pulmonary Arterial Hypertension”, Medical Grand Rounds,
Jamaica Hospital Medical Center, New York, NY, September 4th, 2013.
“Pulmonary Hypertension: An Overview”, Yale Pulmonary Post Doctoral Fellows Summer Lecture Series, Yale
University School of Medicine, New Haven, CT, August 21, 2013
“Pulmonary Hypertension on the Echo: Time to Treat?” Yale Pulmonary Post Doctoral Fellows Summer Lecture
Series, Yale University School of Medicine, New Haven, CT, August 21, 2013
“Understanding Mechanical Ventilation”, Griffin Hospital ICU Teaching Rounds, Derby, CT, August 20, 2013
“Current and Future Therapies in the Treatment of Pulmonary Arterial Hypertension”, Pulmonary Grand Rounds,
Thomas Jefferson University, Philadelphia, PA, June 12th, 2013.
“Applying Targeted Treatment Approaches in the Individual Pulmonary Arterial Hypertension Patient”, Section of
Cardiology, Yale University School of Medicine, June 11th, 2013
“Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension”, 7 th Annual Yale Pulmonary
Hypertension Symposium, Madison, CT, June 6th, 2013
“Pulmonary Hypertension and Pregnancy”, 7th Annual Yale Pulmonary Hypertension Symposium, Madison, CT, June
6th, 2013
“Inhaled and Infused Prostanoid Therapy in the Management of Pulmonary Arterial Hypertension”, 7 th Annual Yale
Pulmonary Hypertension Symposium, Madison, CT, June 6th, 2013
“Pulmonary Hypertension on the Echo: Time to Treat?”, Section of Cardiovascular Disease Post-Doctoral Fellows
Lecture Series, New Haven, CT, May 8th, 2013.
“Precious Body Fluids: Transport of Oxygen and Carbon Dioxide”, Respiratory Physiology Series, Yale Physician
Associates Program, New Haven, CT, January 17th, 2013.
“Pulmonary Hypertension: An Overview”, General Surgery Residency Noontime Lecture Series, Yale New Haven
Hospital, New Haven, CT, November 29th, 2012.
“Interstitial Lung Disease Associated Pulmonary Hypertension”, American College of Chest Physicians Annual
International CHEST Meeting, Atlanta, GA, October 22nd, 2012
“Pulmonary Hypertension and Pregnancy”, American College of Chest Physicians Annual International CHEST
Meeting, Atlanta, GA, October 21st, 2012.
“Pulmonary Hypertension : Case Studies From the Yale Pulmonary Vascular Disease Program”, Yale Pulmonary
Post Doctoral Fellows Summer Lecture Series, Yale University School of Medicine, June 28 th, 2012.
7
“Pulmonary Hypertension on the Echo: Time to Treat?” Yale University School of Medicine Section of Pulmonary &
Critical Care Post-Doctoral Fellows Summer Lecture Series, New Haven, CT, June 28th, 2012.
“Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension”, 6th Annual Yale Pulmonary
Hypertension Symposium, Norwalk, CT, June 7th, 2012.
“Obesity Cardiomyopathy Associated Pulmonary Hypertension: Is it a Distinct Entity?”, 6 th Annual Yale Pulmonary
Hypertension Symposium, Norwalk, CT, June 7th, 2012.
“Infused Prostanoids in the Management of Pulmonary Arterial Hypertension”, 6 th Annual Yale Pulmonary
Hypertension Symposium, Norwalk, CT, June 7th, 2012.
“Improving Outcomes: The Rationale of Combination Therapy and Emerging and Novel Therapies in Pulmonary
Arterial Hypertension”, 6th Annual Yale Pulmonary Hypertension Symposium, Norwalk, CT, June 7th, 2012.
“Obesity and the Lung: Pulmonary Hypertension and Other Maladies”, Greenwich Hospital Affiliate Lecture Series,
Greenwich, CT, May 15th, 2012.
“Current and Future Therapies for Pulmonary Hypertension”, Medical Grand Rounds, Trinitas Regional Medical
Center, Elizabeth, NJ, April 12th, 2012.
“Pulmonary Hypertension on the Echo: Time to Treat? A Rose is a Rose is a Rose…or is it?”, Waterbury Hospital
Affiliate Lecture Series, Waterbury, CT, April 5th, 2012.
“Obesity and the Lung: Pulmonary Hypertension and Other Maladies”, INOVA Advances in Pulmonary & Critical Care
Symposium, Falls Church, Virginia, March 16th, 2012.
“Interstitial Lung Disease, ARDS/Respiratory Failure, and Pulmonary Hypertension”, Yale University School of
Medicine 2nd Year Student Workshops Series, New Haven, CT, March 5th, 2012.
“Asthma, DVT/Pulmonary Embolism, Upper Respiratory Tract Infections”, Yale University School of Medicine 2nd
Year Student Workshops Series, New Haven, CT, February 29th, 2012.
“Pulmonary Hypertension and Sleep Disordered Breathing”, Yale Sleep Medicine Lecture Series, Yale University
School of Medicine, New Haven, CT, February 8th, 2012.
“Precious Body Fluids: Transport of Oxygen and Carbon Dioxide”, Respiratory Physiology Series, Yale Physician
Associates Program, New Haven, CT, January 20th, 2012
“Connective Tissue Disease Associated Pulmonary Hypertension: Lessons from the Reveal Registry”, Rheumatology
Grand Rounds, William Baccus Hospital, Norwich, CT, January 13th, 2012.
“A Crash Course in Pulmonary Hypertension for Cardiology Fellows – Cases from the Yale Pulmonary Vascular
Disease Program”, Cardiology Grand Rounds, Yale Section of Cardiology, Yale University School of Medicine, New
Haven, CT, January 6, 2012.
“Stump the Experts Case Discussion; A 58 Year Old Male with Dyspnea on Exertion”, invited panelist, 9 th Annual
Update in Pulmonary Hypertension, Tufts-New England Medical Center, Cambridge, MA, December 2nd, 2011
“”Applying Targeted Treatment Approaches in the Individual Pulmonary Arterial Hypertension Patient”, American
College of Chest Physicians International Chest Meeting, Honolulu, Hawaii, October 24 th, 2011
“Applying Targeted Treatment Approaches in the Individual Pulmonary Arterial Hypertension Patient”, American
College of Chest Physicians International Chest Meeting, Honolulu, Hawaii, October 25 th, 2011
8
“Classification and Diagnosis of Pulmonary Hypertension: Refinements from the 4th World Symposium at Dana Point,
American College of Chest Physicians International Chest Meeting, Honolulu, Hawaii, October 25 th, 2011
“COPD-Associated Pulmonary Hypertension, Should I Treat This Patient’s Pulmonary Hypertension?”, Chair,
American College of Chest Physicians International Meeting, Honolulu, Hawaii, October 25 th, 2011
“Connective Tissue Disease Associated Pulmonary Arterial Hypertension: Lessons from the EARLY Trial, REVEAL
Registry, and the Chinese National Registry”, Rheumatology Grand Rounds, Yale University School of Medicine,
October 12th, 2011.
“Cases from the Archives of the Yale Pulmonary Hypertension Center”, Yale Medical Housestaff Noon Lecture
Series, New Haven, CT, August 25th, 2011
“New Concepts and Clinical Controversies in Pulmonary Arterial Hypertension”, Pulmonary Grand Rounds, WinthropUniversity Hospital, Mineola, NY, August 23rd, 2011
“Understanding Your Pulmonary Arterial Hypertension and Medications to Treat It”, PH Phorum for patients and
cargivers, Stamford Marriott Hotel, Stamford, CT, August 23rd, 2011.
“Pulmonary Hypertension – An Overview”, Yale University Section of Pulmonary and Critical Care Section Post
Doctoral Fellows Orientation Lecture Series, New Haven, CT, July 1st, 2011
“Pulmonary Hypertension on the Echo – Time to Treat?”, Yale University Section of Pulmonary and Critical Care
Section Post Doctoral Fellows Orientation Lecture Series, New Haven, CT, July 1 st, 2011.
“Medications for Pulmonary Arterial Hypertension – What Every Pulmonary Fellow Needs to Know”, Yale Pulmonary
Fellow Noontime Lecture Series, New Haven, CT, June 14th, 2011.
“Vasodilator Testing: Is it Really Necessary in all Forms of WHO Group I Patients?”, 5 th Annual Yale Pulmonary
Hypertension Symposium, New Britain, CT, June 7th, 2011
“Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension”, 5 th Annual Yale Pulmonary
Hypertension Symposium, New Britain, CT, June 7th, 2011.
“Pulmonary Hypertension: Diagnosis and Treatment Updates”, Medical Grand Rounds, Sisters of Charity Hospital,
State University of New York at Buffalo, Buffalo, NY, April 12th, 2011.
“Asthma, Neuromuscular Disease, and Sleep /Control of Breathing”, Yale University School of Medicine 2nd Year
Student Workshops, New Haven, CT, April 6th, 2011
“Interstitial Lung Diseases: IPF and Sarcoidosis”, Yale University School of Medicine 2 nd Year Student Workshops,
New Haven, CT, March 31st, 2011
“Medical Crossfire: Pulmonary Arterial Hypertension Video Pearls (Series I-IV): An Update on Pathophysiology,
Diagnosis, and Treatment”, Temple University Continuing Medical Education Series, Hackensack, NJ, December
17th, 2010.
“Precious Body Fluids: Transport of Oxygen and Carbon Dioxide in the Blood”, Yale Physican’s Assistance Program,
New Haven, CT , March 21st, 2011.
“ Endothelin Receptor Antagonists”, Eighth Annual Update in Pulmonary
9
Hypertension, Tufts-New England Medical Center, Boston, MA, December 3rd, 2010. Syllabus developed for
distribution to attendees.
“Pulmonary Hypertension Causes: Beyond PAH”, American College of Physicians
Annual International Meeting, Vancouver, Canada, November 4th, 2010.
“Vasodialator Challenge Is an Absolute Standard of Care in the Diagnosis of PH”
Pro/Con Debate, American College of Chest Physicians Annual International Meeting,
Vancouver, Canada, November 2nd, 2010.
“Pulmonary Hypertension –What Every House Officer Needs to Know”, Yale Housestaff Noon Lecture Series, Yale
University School of Medicine, New Haven, CT, October 1st, 2010.
“Pulmonary Hypertension on the Echo – Time to Treat?, Post Doctoral Fellows Summer Pulmonary and Critical Care
Lecture Series, Yale University School of Medicine, New Haven, CT, July 14, 2010.
“Pulmonary Hypertension – An Overview”, Post Doctoral Fellows Summer Pulmonary and Critical Care Lecture
Series, Yale University School of Medicine, New Haven, CT, July 2 nd, 2010.
“Classification and Diagnosis: Refinements from the 4th World Symposium on Pulmonary Hypertension at Dana
Point, CA”, 4th Annual Pulmonary Hypertension Symposium, Updates on Classification and Therapies, East Haddam,
CT, June 3rd, 2010.
Syllabus prepared for this symposium and available for review.
“Calcium Channel Blockers in PAH: Should They Still Be Used?”, Annual Pulmonary Hypertension Symposium,
Updates on Classification and Therapies, East Haddam, CT, June 3rd, 2010. Syllabus prepared for this symposium
and available for review.
“Endotheliin Receptor Antagonists: Old Friends, Reflections on the EARLY Trial, and Potential New Additions to the
Armentarium”, 4th Annual Pulmonary Hypertension Symposium, Updates on Classification and Therapies, East
Haddam, CT , June 3rd, 2010. Syllabus prepared for this symposium and available for review
“Pulmonary Hypertension and Obesity Cardiomyopathy: Is it a Distinct Entity and How Should We Treat It?”, State
Chest Conference, Yale University, New Haven, CT, April 7th, 2010.
“Pulmonary Hypertension on the Echo: Time to Treat?”, Section of Pulmonary Medicine, Winthrop-University
Hospital, State University of New York at Stony Brook, Mineola, NY, March 11, 2010.
“Clinical Conundrums in Pulmonary Hypertension: Tough Cases and What to Do About Them”, Pulmonary
Associates of Northern Long Island, Rosyln, NY, March 10, 2010
“An Overview of Pulmonary Hypertension- Diagnosis and Treatment”, West Haven Veteran’s Administration Hospital
Houses Staff Noon lecture, West Haven, CT, December 22nd, 2009.
“Portopulmonary Hypertension”, Yale New Haven Liver Transplant Program Grand Rounds, New Haven, CT,
December 16th, 2009.
“Pulmonary Hypertension: An Overview and Update”, St. Mary’s Hospital, Waterbury, CT, December 15 th, 2009.
“An Update on What’s New in Pulmonary Hypertension”, St. Lukes/Roosevelt Interventional Cardiologists Round
Table, New York, NY, November 12th, 2009.
“Evolving Complexities and New Therapeutic Strategies in Pulmonary Arterial Hypertension”, Invited Panel Member,
American College of Chest Physicians Annual International Meeting, San Diego, CA, November 3 rd, 2009
10
“Vexing Vessels”, Invited Expert Moderator, American College of Chest Physicians Annual International Meeting, San
Diego, CA, November 3rd, 2009.
“Medical Therapies for Chronic Thromobembolic Pulmonary Hypertension”, American College of Chest Physician’s
Annual International Meeting, San Diego, CA, November 2 nd, 2009
“Diastolic Dysfunction, Obesity Cardiomyopathy, and Elevated Transpulmonary Gradients Even After the Wedge
Pressure is Normalized – What’s a Cardiologist to Think?”, Cardiopulmonary Grand Rounds, Middlesex Hospital,
Middletown, CT, October 6th, 2009
“Pulmonary Hypertension – An Overview and Update on New Therapies”, Medical Grand Rounds, Memorial Sloan
Kettering Cancer Center, New York, NY, September 18, 2009.
“Pulmonary Hypertension – An Overview”, Eastern Carolina Medical Center Pulmonary Grand Rounds, Greenville,
NC, July 15th, 2009.
“Pulmonary Hypertension on the Echo: Time to Treat”, Eastern Carolina Medical Center Cardiopulmonary Round
Table, Greenville, NC, July 14th, 2009
“”Pulmonary Hypertension and Other Associated Conditions: Lung Disease, Heart Disease, Thyroid Disease”, PH
Patients and Families Education Forum, A Program of the Pulmonary Hypertension Association Medical Education
Fund, Warwick, RI, June 13, 2009.
“An Overview of the Classification of and Proper Diagnosis of Pulmonary Arterial Hypertension”, 3 rd Annual Yale
Pulmonary Hypertension Symposium, What to Do with WHO Class I,II, and III patients, West Hartford, CT, June 4 th,
2009.
“Pulmonary Hypertension and Obesity Cardiomyopathy: is it a Distinct Entity?”, American Thoracic Society
International Annual Meeting, San Diego, CA, May 17th, 2009.
“Precious Body Fluids: Oxygen and Carbon Dioxide Transport”, Yale University Physician Assistant Program
Respiratory Physiology Lecture Series, Yale University, New Haven, CT, May 5th, 2009.
“Elevated Pulmonary Pressures on an Echo: Time to Treat?”, Pulmonary Grand Rounds, Sloan Kettering Memorial
Cancer Center, New York, NY, April 15th, 2009.
“Interstitial Lung Diseases: IPF and Sarcoidosis”, Yale University School of Medicine 2nd Year Student Workshops,
New Haven, CT, January 20th, 2009
“Asthma, Neuromuscular Disease, and Sleep /Control of Breathing”, Yale University School of Medicine 2ne Year
Student Workshops, New Haven, CT, January 15th, 2009.
“Diastolic Dysfunction, Obesity Cardiomyopathy, and Elevated Transpulmonary Gradients Even After the Wedge
Pressure is Normalized – What’s a Cardiologist to Think?”, Cardiopulmonary Grand Rounds, Stamford Hospital,
Stamford, CT , January 15th, 2009
“Connective Tissue Disease Associated Pulmonary Hypertension – An Update”, Rheumatology Grand Rounds, Yale
University School of Medicine, November 19th, 2008
“Pulmonary Hypertension on the Echo: Time to Treat?”, Medical Grand Rounds, St. Vincent’s Medical Center,
Bridgeport, CT, November 4, 2008.
11
“Mechanical Ventilation: The Basics”, Yale Internal Medicine Housestaff Emergency Medicine Lecture Series, New
Haven, CT, August 7th, 2008.
“Classification and Diagnosis of Pulmonary Hypertension”, Yale State Chest Conference Fellows Summer Lecture
Series, New Haven, CT, July 23rd, 2008.
“Current and Future Therapies for Pulmonary Hypertension: A Review of Emerging Cellular Pathways”, Yale State
Chest Conference Fellows Lecture Series, New Haven, CT, July 23rd, 2008.
“Treatment of Pulmonary Hypertension: Oral Dual Endothelin Receptor Antagonism and Inhaled Prostacylcin”,
Philadelphia, PA, July 9th, 2008
“Pulmonary Hypertension: An Overview”, Internal Medicine Grand Rounds, Christiana Care Medical Center, Newark,
DE, July 10th, 2008.”
“Alpha-1 Antitrypsin Deficiency-From Discovery to Treatment”, Greenwich Hospital Noon Housestaff Lecure Series,
Greenwich, CT, June 12th, 2008.
“Classification and Diagnosis of Pulmonary Hypertension”, 2 nd Annual Yale Pulmonary Hypertension
Symposium, Westport, CT, June 6th, 2008
Syllabus developed and distributed to course attendees.
“Incidence and Factors Affecting Survival I Pulmonary Arterial Hypertension”, 2 nd Annual Yale Pulmonary
Hypertension Symposium, Westport, CT, June 6th, 2008.
Syllabus developed and distributed to course attendees
“Connective Tissue Disease Associated Pulmonary Arterial Hypertension”, 2 nd Annual Yale Pulmonary
Hypertension Symposium, Westport, CT, June 6th, 2008.
Syllabus developed and distributed to course attendees.
“Preoperative Risk Assessment for Post-operative Pulmonary Complications, Internal Medicine Grand Rounds,
Greenwich Hospital, Greenwich, CT, May 30th, 2008.
“Pulmonary Hypertension on the Echo – Time to Treat?,
Cardiology Grand Rounds, Saint Vincent Medical Center, New York, NY, May 15th, 2008.
“Pharmocotherapy for Pulmonary Hypertension”, Cardiovascular Disease in Williams-Beuren Syndrome:
Understanding Pathophysiology to Pioneer Treatment, Yale University Vascular Biology and Therapeutics Program,
Yale University School of Medicine, New Haven, CT, May 9th, 2008.
“Pulmonary Hypertension: An Overview”, Medical Grand Rounds, Windham Hospital, Windham, CT, April 21, 2008.
“Pulmonary Hypertension: An Overview”, Medical Grand Rounds, Gaylord Rehabilitation Hospital, Wallingford, CT,
March 25, 2008.
“Connective Tissue Disease Associated Pulmonary Arterial Hypertension”, Rheumatology Grand Rounds, Montefiore
Medical Center, Albert Einstein College of Medicine, February 29, 2008.
“Distinguishing Pulmonary Venous Hypertension From Other Forms of Pulmonary Hypertension: What is a Normal
Transpulmonary Gradient?, Dayton Cardiovascular Associates, Dayton, Ohio, February 20, 2008.
“Pulmonary Hypertension: Getting the Diagnosis Right”, Medical Grand Rounds, Good Samaritan Medical Center,
Cincinnati, Ohio, February 20, 2008.
12
“Pulmonary Hypertension: A Rose is a Rose is a Rose….”, Medical Grand Rounds, Westchester Medical Center,
New York Medical College, Valhalla, NY, January 2nd, 2008.
“Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension”, Fifth Annual Update in
Pulmonary Hypertension, Tufts-New England Medical Center, Boston, MA, November 30, 2007.
“Pulmonary Arterial Hypertension: Getting the Diagnosis Right!”, Roger Williams Hospital, Boston University School
of Medicine Affiliate, Providence, RI, November 20, 2007.
“Classification and Diagnosis of Pulmonary Hypertension”, Fellows Program in Pulmonary Hypertension, Lecturer
and Chair, Eastern Seaboard Meeting, Ft. Lauderdale, Fl, November 17th, 2007.
“Pulmonary Hypertension: An Overview”, Emergency Medicine Residency Housestaff Lecture Series, Yale University
School of Medicine, October 17th, 2007.
“Chairman, ABIM Pulmonary Board Review Course and Faculty Presenter, American College of Chest Physicians
International Conference, Chicago, Il, October 20th, 2007.
“When It’s Time to Treat Your Patient Part 2: Choosing Treatment, Assessing Response, and Refining Strategies”
Pulmonary Arteral Hypertension: Current Approaches and Future Expectations for Clinicians and Patients. Mulit-City
CME Course Sponsored by the University of Michigan, PHAssociation, and the Scleroderma Foundation, Miami, Fl,
October 6th, 2007
“Pulmonary Hypertension: A Rose is A Rose…”, Medical Grand Rounds, Norwalk Hospital, Norwalk, CT, October 4th,
2007.
“Portopulmonary Hypertension: Incidence, Pathophysiology, and Prognosis”, 2 nd Annual Northern New England
Pulmonary Hypertension Symposium, Bedford, NH, October 1st, 2007.
“Balancing Evidence and Clinical Reality: Case Presentations and Panel Discussion, Lecturer, Moderator, and
Chairman, Pulmonary Arteral Hypertension: Current Approaches and Future Expectations for Clinicians and Patients.
Mulit-City CME Course Sponsored by the University of Michigan, PHAssociation, and the Scleroderma Foundation,
New York, NY September 8, 2007.
“Pulmonary Hypertension: An Overview”. Yale Internal Medicine Housestaff Noon Lecture Series, New Haven, CT
August 28, 2007
“Pulmonary Hypertension- Classification and Diagnosis”, Yale State Chest Conference Fellows Summer Lecture
Series, July 25th, 2007
“Pulmonary Hypertension –Current and Emerging Therapies”, Yale State Chest Conference Fellows Summer Lecture
Series, July 25, 2007.
“Pulmonary Hypertension : Incidence, Patterns of Presentation, and Predictors of Survival”, First Annual Pulmonary
Hypertension Symposium, Yale University School of Medicine, Department of Internal Medicine and Section of
Pulmonary and Critical Care Medicine, Water’s Edge Conference Center, Westbrook, CT, June 1, 2007
.
“Classification and Diagnosis of Pulmonary Hypertension”, First Annual Pulmonary Hypertension Symposium, Yale
University School of Medicine, Department of Internal Medicine and Section of Pulmonary and Critical Care
Medicine, Water’s Edge Conference Center, Westbrook, CT, June 1, 2007.
13
“Diagnostic Challenges in Pulmonary Hypertension: Are We Failing to Treat Patients in Need?”, New Frontiers in
Pulmonary Hypertension Postgraduate Course of the American Thoracic Society International Conference, San
Francisco, CA, May 20th, 2007.
“Pulmonary Hypertension: An Overview”, Medical Grand Rounds, Waterbury Hospital, Waterbury, CT, April 27 th,
2007.
“Pulmonary Hypertension: A Rose is A Rose is A Rose….?”, Case Based Teaching Session with medical housestaff,
Jewish Hospital, Cincinnatti, OH, April 24th, 2007.
“Pulmonary Hypertension: An Overview”, Medical Grand Rounds, Jewish Hospital, Cincinnatti, OH, April 24 th, 2007.
“A Round Table Discussion of Pulmonary Hypertension: Why the Right Heart Cath?”, Cardiopulmonary Associates of
Northern Kentucky, April 23, 2007.
“Pulmonary Arterial Hypertension: An Overview”, Danbury Hospital Housestaff Teaching Rounds, Danbury, CT, April
17, 2007.
“Precious Body Fluids: Oxygen and Carbon Dioxide Transport in the Blood”, Yale School of Physician Assistants
Physiology Lecture Series, April 16, 2007
“Diagnostic Pitfalls in Pulmonary Hypertension: The Proper Role of Echocardiography”, Cardiology Grand
Rounds,Fuqua Heart Center, Crawford Long Hospital, Emory University School of Medicine, March 29 th, 2007.
“New Strategies in Assessing Therapeutic Success for Pulmonary Hypertension”, Cardiopulmonary Associates of
Myrtle Beach, Myrtle Beach, SC, March 28th, 2007.
“Connective Tissue Associated Pulmonary Hypertension”, Rheumatology Grand Rounds, Yale University School of
Medicine, New Haven, CT, January 31, 2007.
“Pulmonary Arterial Hypertension: An Overview”, Medical Grand Rounds, Sound Shore Medical Center, New
Rochelle, NY, January 12, 2007.
“Fellows Program in Pulmonary Arterial Hypertension: Strategies for Clinical Practice”, Steering Committee Faculty
and Chair, Northeast US Session, Woodcliff Lakes, NJ, December 1-2, 2006
“Classification and Diagnosis of Pulmonary Hypertension”, Fellows Program in Pulmonary Arterial Hypertension:
Strategies for Clinical Practice, Woodcliff Lakes, NJ, December 2, 2006.
“Pulmonary Hypertension: An Overview of Classification, Diagnosis, and Treatment”, Cardiovascular Associates of
Fairfield, Fairfield, CT, November 21, 2006
“Stump the Experts – Case Presentations in Pulmonary Hypertension”, 4th Annual Update in Pulmonary
Hypertension, Tufts-New England Medical Center, Boston, MA, November 17th, 2006.
“Yale University School of Medicine Student Workshop in Respiratory Diseases”, Yale University School of Medicine,
New Haven, CT, November 16, 2006.
“Yale University School of Medicine Student Workshop in Respiratory Diseases”, Yale University School of Medicine,
New Haven, CT, November 7, 2006
“Evolving Treatment Strategies in PAH: 2006 Update”, Pulmonary Arterial Hypertension; Today and Tomorrow CME
program sponsored by the University of Michigan and Pulmonary Hypertension Association, Philadelphia, PA,
November 4, 2006.
14
“Current and Future Therapies for Pulmonary Arterial Hypertension”, Vascular Biology Translational Work Group,
Yale University School of Medicine, New Haven, CT, October 31, 2006.
“Case Studies in Pulmonary Hypertension: Beware the Case of Mistaken Identity”, Cardiopulmonary Grand Rounds,
Backus Hospital, Norwich, CT, October 13, 2006.
“Pulmonary Hypertension: An Update”, Medical Grand Rounds, Midstate Medical Center, Meriden, CT, October 6,
2006.
“Pulmonary Hypertension: A Changing Paradigm”, Medical Grand Rounds, Auxilio Mutuo Hospital, San Juan, Puerto
Rico, September 22, 2006.
“Connective Tissue Disease Associated Pulmonary Hypertension”, Rheumatology Grand Rounds, Hospital Centro
Medico, San Juan, Puerto Rico, September 21, 2006.
“Pulmonary Hypertension: A Rose is a Rose is a Rose…?, Journal Club, Puerto Rico Association of Pulmonologists,
San Juan, Puerto Rico, September 21, 2006.
“Pulmonary Hypertension: The Importance of the Right Heart Cath”, Pulmonary Grand Rounds, Middlesex Hospital,
Middletown, CT, August 30, 2006.
“Pulmonary Hypertension: A Rose is A Rose is A Rose….? Medical Grand Rounds, Yale University School of
Medicine, New Haven, CT, August 24th, 2006.
“Emerging Therapies for Pulmonary Hypertension”, Section of Pulmonary and Critical Care Fellows Lecture Series,
Yale University School of Medicine, August 9th, 2006.
“The Diagnosis of Pulmonary Hypertension”, Brown University First Annual Symposium on Pulmonary Hypertension,
Newport, RI, July 28th, 2006.
“Hemoglobinopathies and the Development of Pulmonary Hypertension: What Do We Know? Yale University School
of Medicine Hematology Grand Rounds; June 14th, 2006.
“Pulmonary Hypertension: Pitfalls in the Diagnosis and Treatment”, Medical Grand Rounds, Queens Hospital Center,
Jamaica, NY, May 31st, 2006.
“The Pulmonary Artery Catheter: Intelligent Use in the ICU Patient”, Yale Internal Medicine Housestaff Lecture
Series, New Haven, CT,May 10, 2006
“Pulmonary Hypertension: Our Current Understanding”, Carmel, New York, April 26th, 2006.
“Toward Earlier Diagnosis of Pulmonary Hypertension: Where are the Impediments?”, Actelion Scientific Advisory
Board, New York, New York, April 21st, 2006.
“Pulmonary Hypertension Potpourri: Controversies in the Use of Right Heart Catheterization, Stress
Echocardiography, and Combination Therapy”, Bowman Gray School of Medicine Division of Pulmonary Medicine
Grand Rounds, Wake Forest University, Winston-Salem, NC, April 20th, 2006.
“Future Therapeutic Targets in Pulmonary Hypertension”, University of North Carolina School of Medicine at Chapel
Hill, Pulmonary Division Grand Rounds, April 19th, 2006
“Central Venous Pressure Monitoring: Common Misconceptions”, Yale Internal Medicine Housestaff Lecture Series,
January 23, 2006.
15
“Potential New Targets in the Treatment of Pulmonary Arterial Hypertension”, Winthrop-University Hospital
Pulmonary Grand Rounds, January 19, 2006.
“Precious Body Fluids: Oxygen and Carbon Dioxide Transport in the Blood”, Yale School of Physician Assistants
Physiology Lecture Series, January 17, 2006
“Current and Future Therapies of Pulmonary Hypertension”, Yale State Chest Conference, New Haven, CT, September
7th, 2005.
“Mechanical Ventilation: The Basics”, Yale Affiliate Lecture Series, Greenwich Hospital, August 25,2005.
“Pulmonary Hypertension: A Shifting Paradigm”, Medical Grand Rounds at Elliot Hospital, Schnectady, NY, April 11,
2005.
“Therapies for Pulmonary Hypertension: A Look at Novel Targets for Future Therapies”, Albany, NY, April 10, 2005.
“Alpha-1 Antitrypsin Deficiency: From Bench to Bedside”, Winthrop-University Hospital Medical House Staff Core
Lecture Series. Mineola, NY, December 7th, 2004
“Mechanical Ventilation.” Winthrop-University Hospital Medical House Staff Core Lecture Series, Mineola, NY
November 2, 2004.
“Pulmonary Hypertension: Classification, Diagnosis, and Prognosis.” Actellion Pharmacy Advisory Board Meeting.
Baltimore, MD. October 13, 2004.
“Lung Anatomy and Physiology: The Basics.” New York Association of Cancer Registrars Annual Education
Conference. Port Jefferson, NY. October 7, 2004.
“The Pulmonary Artery Catheter: Use in The MICU.” Winthrop University Hospital – Pulmonary Division Fellows
Lecture Series. Mineola, NY. July 22, 2004.
“Shock Talk.” Winthrop-University Hospital – Pulmonary Division Fellows Lecture Series, Mineola, NY, July, 2004.
“Future and Current Treatments in Pulmonary Hypertension.” Winthrop-University Hospital - Pulmonary
Hypertension Center CME Symposium. Mineola, NY. May 14, 2004.
“Critical Care.” Winthrop-University Hospital Internal Medicine Board Review Course. May 7, 2004.
“Pulmonary Hypertension- A Shifting Paradigm.” Pulmonary Grand Rounds, University of Pittsburgh School of
Medicine. Pittsburgh, PA. May 4, 2004.
“Pulmonary Hypertension-A Shifting Paradigm.” Pulmonary Grand Rounds, Memorial Sloan-Kettering Cancer Center
New York, NY. April 21, 2004.
“Pulmonary Hypertension – A Shifting Paradigm.” Medical Grand Rounds, St. John’s Hospital. Queens, NY. February
13, 2004.
“Pulmonary Hypertension-A Shifting Paradigm”. Medical Grand Rounds, Brookdale Hospital. Brooklyn, NY. February
11, 2004.
16
“ARDS & Ventilation Management.” Winthrop-University Hospital Medical House Staff Core Lecture Series. January
22, 2004.
“Corticosteroids in Pulmonary Sarcoidosis-Can That Dog Hunt?”, Yale State Chest Conference, Yale Unviversity
School of Medicine, New Haven, CT, December 17, 2003
“Lipoid Pneumonia”. Yale Pulmonary & Critical Care Fellows Didactic Conference, Division of Pulmonary & Critical
Care. Yale University, New Haven, CT. December 17, 2003
“ Pulmonary Hypertension-A Shifting Paradigm”. Western Connecticut Association of Critical Care Nurses. Danbury
Hospital. Danbury, CT. November 20, 2003.
“Pulmonary Hypertension-A Shifting Paradigm”. Medical Grand Rounds, South Nassau Community Hospital.
Oceanside, NY. November 18, 2003.
“Pre-operative Assessment of the Risk of Post-op Pulmonary Complications”. Winthrop-University Hospital Medical
House Staff Core Lecture Series. November 18, 2003.
“Pulmonary Hypertension-A Shifting Paradigm” Medical Grand Rounds, Community Medical Center, Scranton, PA.
November 11, 2003.
“Pulmonary Hypertension-Case Studies in Mangagment Decisions”, Cardio-Thoracic Group of Scranton, Scranton,
PA, Novemeber 10, 2003.
“Pulmonary Hypertension-Where Are We Going?” Pulmonary Hypertension Association Annual Fund Raising
Luncheon, Douglaston, NY. November 3, 2003.
“Mechanical Ventilation: The Basics”. Winthrop University Hospital Medical House Staff Core Lecture Series. July,
2003.
“Pulmonary Hypertension-A Clinician’s Perspective”. Danbury Hospital-Pathology Residency Program Continuing
Education Lecture Series. Danbury, CT. January, 1998.
“Non-invasive Mask Ventilation: Who, When and How?” Danbury Hospital-Dept. of Emergency Medicine Grand
Rounds. Danbury, CT. October 1997.
“Perflucarbon Liquid Ventilation-An Update”. Yale Summer Lecture Series for Critical Care Fellows. Yale University
School of Medicine. New Haven, CT. August 1997.
“Persistent Cough with Pulmonary Infiltrates; A CPC & Case Discussion”. Danbury Hospital Grand Rounds. Danbury
CT. April 1997.
“Asthma-What You Need to Know”. Medical Town Meeting. Danbury, CT. April 1997.
“Building Your Medical Practice”. Planning a Career in Pulmonary Medicine, Postgraduate Course #17. American
Thoracic Society International Conference. New Orleans, LA. May 1997.
“Alpha – 1 Antitrypsin Deficiency – From Bench to Bedside.” Pulmonary Grand Rounds, Maine Medical Center.
Portland, ME. December 1996.
17
“The Benefits of a Good Night’s Sleep: A Discussion of Sleep Disorders”. Medical Town Meeting. Ridgefield, CT.
November 14, 1996.
“Corticosteroids Alter the Long-Term Outcome of Pulmonary Sarcoidosis-A Pro/Con Debate”. Yale State Chest
Conference. Yale University. New Haven, CT. November 13, 1996.
“Non-Conventional Modes in Mechanical Ventilation-An Update”. Yale Summer Lecture Series for Critical Care
Fellows. Yale University. New Haven, CT. August 1996.
“All That Wheezes Is Not Asthma”. Danbury Hospital Grand Rounds. Danbury, CT. August 1996.
“Lung Cancer-New Thoughts on Staging & Treatment”. Saint Francis Hospital & Medical Center Grand Rounds.
Hartford, CT. January 1996.
“Pulmonary Hypertension: An Overview”. Danbury Hospital Grand Rounds. Danbury, CT. September 1996.
“Asthma-The NHLBI Recommendations for Management”. Primary Care Round Table. Wilton, CT. November 1995.
“Asthma-Triggers, Controllers, and Relievers”. Community Town Meeting. Ridgefield, CT. October 1995.
“Future Directions in Lung Cancer”. Norwalk Hospital-Dept. of Pulmonary Medicine. Norwalk, CT. January 1995.
“Auto-Peep: Why Should You Worry About It?” Danbury Hospital Dept. of Respiratory Therapy Continuing Medical
Education Seminars. Danbury, CT. October 1994.
“Newer Modes of Mechanical Ventilation”. Danbury Hospital Western Connecticut Critical Care Nurses Association.
Danbury, CT. October 1994.
“Controversies in Asthma: Beta-Agonists, Atrovent’s Role, and Lipo-oxygenase Inhibitors”. Resident Primary Care
Lecture Series. Yale University. New Haven, CT. September 1994.
“Pressure Limited Strategies in Ventilation”. Yale Summer Lecture Series for Critical Care Fellows. Yale University.
New Haven, CT. August 1994.
“Physician Assisted Suicides: One Intensivist’s Perspective”. Featured Lecturer. Summer Course on Medical Ethics.
Universidad Internacional Menendez Pelayo. La Coruna, Spain. July 1994.
“Medical Futility in the Intensive Care Unit: Who Decides?” Featured Lecturer. Summer Course on Medical Ethics.
Universidad Internacional Menendez Pelayo. La Coruna, Spain. July 1994.
“Do New Modes of Mechanical Ventilation Have a Role in Your ICU?” Norwalk Hospital-Resident Lecture Series.
Norwalk, CT. March 1994.
“Interleukin 11: Researching a Novel Cytokine & It’s Potential Clinical Implications”. Clinical Science Lecture Series.
Lawrence Memorial Hospital. New London, CT. March 1994.
“Nodular Infiltrates in the Lung”. A CPC & Case Discussion. Danbury Hospital-Grand Rounds. Danbury, CT. October
1993.
“Allergic Bronchopulmonary Aspergillosis: A Case Presentation & Dilemmas in Diagnosis”. Residents Teaching
Forum. Greenwich Hospital. Greenwich, CT. December 1993
18
“Newer Modes of Mechanical Ventilation”. Connecticut State Chest Conference. Yale University. New Haven, CT.
May 1993.
“Community Acquired Pneumonia”. School of Physician Assistants. Yale University. New Haven, CT. January 1992.
PUBLICATIONS:
PEER REVIEWED:
1.)Gutierrez A, Sauler M, Mitchell JM, Siegel MD, Trow TK, Bachetta M, Fares WH. Unresolved
pulmonary embolism leading to a diagnosis of pulmonary artery sarcoma. Heart and Lung 2014, : .
2.)Trow TK. Recent findings on pulmonary hypertension. Clin Chest Med 2013; 34: xii-xiv
3.)Forfia PR, Trow TK. Diagnosis of pulmonary hypertension. Clin Chest Med 2013; 34: 665-682.
4.)Sauler M, Fares WH, Trow TK. Standard nonspecific therapies in the management of pulmonary
arterial hypertension. Clin Chest Med 2013;34:799-810
5.)Cho WK, Lee CM, Kang MJ, Huang Y, Giordano FJ, Lee PJ, Trow TK, Homer RJ, Sessa WC,
Elias JA, Lee CG. IL-13 induces pulmonary vascular remodeling and hemodynamic changes via an IL-13
receptor α2-arginase2-dependent pathway. 2012 American Journal of Physiology - Lung Cellular and
Molecular Physiology 2013, 304: L112-L124.
6.) Fares WH,Trow, TK, Targeted approaches to treatment of pulmonary hypertension. Thera Adv Resp
Dis 2012; 6(3): 147-149. DOI:10.1177/1753465812441849..
7.) Li W, Niu B, Henderson K, Northrup V, Pollock JS, Trow TK, Fahey J, White RI. Reproducibility of
oxygen saturation monitoring during six-minute walk test and exercise stress test in patients with
pulmonary arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Pediatr
Cardiol 2011; 32:590-594. Epub 2011 Feb 19.
8.) Lane CR, Trow TK. Pulmonary hypertension and pregnancy. Clin Chest Med 2011; 32: 165-174.
9.) Trow TK, Argento A.C, Rubinowitz AN, Decker R. A 71-year-old woman with myelofibrosis,
hypoxemia, and pulmonary hypertension. Chest, 2010; 138:1506-1510.
10.) Auger WR, Kim NH, Trow TK. Chronic thromboembolic pulmonary hypertension. Clin Chest Med
2010;31:741-758.
11.) Trow TK, Elliott CG. Venous thromobembolism. Clin Chest Med 2010; 31:xi-xii.
12.) Berg AM, Smirbekina S, Mojibian H, Trow TK, Smith SJ, White RI. Hemothorax due to rupture of
pulmonary arteriovenous malformation. An interventional emergency. Chest 2010; 137: 705-707.
13.) Trow TK, Taichman DB. Endothelin receptor blockade in the management of pulmonary arterial
hypertension: Selective and dual antagonism, Resp Med 2009, 103:951-962.
14.) Trow TK, Morris DG, Miller CR, Homer RJ. Granulomatous bronchiolitis of Crohn’s disease
successfully treated with inhaled budesonide, Thorax 2009, 64:546-547.
15.) Vartany E, Caldwell CA, Trow TK. Adult respiratory distress syndrome after treatment with
pegylated interferon α-2a and ribavirin. Heart & Lung 2008; 37:153-156.
16.) Trow TK, Mannam P. (2008) Evaluation of Pleuritis. British Medical Journal, Point of Care (on line
monograph)
19
17.) Curran DM, Trow TK, Muhs B, Sergi, M. “Pulmonary hypertension after surgical laminectomy: an
easily missed cause of a high output state”, Am J Med 2008 ; 121(8):e3-34.
18.) McArdle JR, Trow TK, Lerz K. Pulmonary hypertension in older adults. Clin Chest Med 2007;
28:717-733.
19.) Trow TK. Executive summaries: clinical year in review 2007; introduction. Proc Am Thor Soc 2007;
4:477.
20.) Trow TK, McArdle JR. Diagnoses of pulmonary arterial hypertension, Clin Chest Med, 2007;
28(1):59-73.
21.) Winger DI, Speigler P, Trow TK, Goyal A., Yung E, Katz DS. Pulmonary hyalinizing granuloma
associated with lupus-like anticoagulation and Morvan’s sydrome. Clinical Imaging 2007; 31:264-268.
22.) Neuman J, Rosioreanu A, Schuss A, Turi G, Yung E, Trow TK, Williams L, Katz DS. RadiologyPathology Conference: Sclerosing hemangioma of the lung. Clinical Imaging 2006; 30:409-412.
23.) Trow TK. Clinical Year in Review II: occupational lung disease, pulmonary vascular disease,
bronchiectasis, chronic obstructive lung disease. Proc Am Thor Soc 2006; 3(7);557-560.
24.) Trow TK. Clinical Year in Review I: diagnostic imaging, asthma, lung transplantation, interventional
pulmonology. Proc Am Thor Soc 2006; 3(7):553-556.
25.) Trow TK. Clinical Year in Review II: pulmonary infections, diagnostic imaging, pleural disease,
neuromuscular disease. Proc Am Thor Soc 2005; 2:175-178.
26.) Trow TK. Clinical Year in Review I: lung cancer, interventional pulmonology, noninvasive mask
ventilation, and pulmonary vascular disease. Proc Am Thorac Soc 2005;2:102-104.
27.) Jain M, Yung E, Trow TK, Katz DS. “F-18 FDG PET Demonstration of Pulmonary Carcinoid”. Clinical
Nuclear Medicine, 2004; 29 (6): 370-371.
28.) Andalkar L, Trow TK, Katz.DS. “Bronchobiliary Fistula as a Complication of Liver Metastases
Diagnosed by HIDA Scan”. Clinical Nuclear Medicine, 2004; 29 (5): 289-291.
29.) Trow TK. “Lung-Volume-Reduction Surgery for Severe Emphysema: Appraisal of Its Current Status.”
Current Opinions in Pulmonary Medicine, 2004; 10 (2) 128-132.
30.) Moss M, Trow TK, Clardy N. “Differences in Response Times of Pages Originating From an ICU”.
Chest 1999; 116: 1019-24.
31.) Elias J, Zheng T, Einarson O, Landry MM, Trow TK, Repert N, Panuska J.“Epithelial interleukin-11:
regulation by cytokines,respiratory syncytial virus and retinoic acid.” Journal of Biological Chemistry, 1994;
269 (35): 22261-68.
32.) Elias J, Whiting NL, Zheng T, Mercovich A, Trow TK. “Cytokine-cytokine synergy and protein kinase
C in the regulation of lung fibroblast leukemia inhibitory factor.” American Journal of Physiology, 1994;
(10): L426-35.
33) Elias J, Zheng T, Whiting NL, Trow TK, Merrill W, Zitnick R, Ray P, Alderman E. “Interleukin –1 and
transforming growth factor B regulation of fibroblast-derived interleukin 11.” Journal of Immunology, 1994;
152: 2421-30.
BOOK CHAPTERS:
1.) Trow, TK, Matthay RA. Management of venous thromboembolism in the critically ill obese patient, in
Critical Care Management of the Obese Patient; Sol AE, editor,Wiley-Blackwell, 2012. pp 108-115.
2) Trow TK, McLauglin VV. Pulmonary Hypertension. In : Lang F, editor, Encyclopedia of Molecular
Mechanisms of Disease, 1st edition, Heidelberg: Springer-Verlag; 2009. pp 1771-1773.
3) Chronister RB. , Sikes. RW, Trow TK, DeFrance JF. “The Organization of Nucleus Accumbens” in The
Neurobiology of the Nucleus Accumbens.” Haer Institute for Electrophysiological Research 1980; 99: 97147.
20
NON-PEER REVIEWED:
1.) Trow TK, Foley R, Klinger J. World Health Organization Groups II and III Pulmonary Hypertension:
When and How to Treat. Pulmonary and Critical Care Updated (PCCU) 2009; 23 (Lesson 9).
2.) Trow TK, Khan N. PAH: Classification, diagnosis, and prognosis. Focus on pulmonary hypertension.
J Resp Diseases 2007; S5-S11.
3.) Mannam P, Trow TK. Pulmonary hypertension in the elderly – more common than we thought. Clin
Pulm Med 2007; 14: 240-242.
4.) Cho WK, Trow, TK. Combination therapy in the treatment of pulmonary arterial hypertension - can
that dog hunt? Clin Pulm Med 2007; 14: 242-243.
5.) Trow TK, McArdle JR. Endothelin receptor blockade in the treatment of pulmonary hypertension:
Less is more…or is it? US Respriratory Disease 2006 Issue II; 2006; 2:30-32.
6.) McArdle JR, Trow TK. Evolving concepts in the pathogenesis and treatment of pulmonary arterial
hypertension. Pulmonary and Critical Care Update (PCCU) 2007; 21(Lesson 9).
7.) Trow TK, Kahn N. Pulmonary Arterial Hypertension: Classification, Diagnosis and Prognosis, J Resp
Dis 2006 27; 487-493.
8.) Castiller F, Trow TK. “Fine tuning” the use of inhaled steroids. Clin Pulm Med 2005; 12:324-326.
9.) Trow TK. In search of an understanding: pulmonary hypertension in chronic obstructive pulmonary
disease. Clin Pulm Med 2005; 12:326-327.
10.) Trow, TK. Initial diagnostic testing in the evaluation of pulmonary hypertension. Advances in
Pulmonary Hypertension 2005; 4:11-14.
11.) Castiller F, Trow TK. Surviving pulmonary hypertension: an oral alternative? Clin Pulm Med
2005;12:281-282.
12.) Anderson JF, Trow TK. To lyse or not to lyse: that is the question. Clin Pulm Med; 2005 12:282-284.
13.) Magin AF, Trow TK, “Getting down and dirty: the effect of an education program on the incidence of
central venous catheter infections”. Clin Pulm Med, 2005 ;12:130-132
14.) Weiss HS, Trow TK, “Clinical criteria to diagnose acute respiratory distress syndrome: how good are
we?” Clin Pulm Med, March 2005 ;12: 132-134.
15.) Trow TK. “Detecting smaller lung cancers – size does matter”. Clin Pulm Med, January 2005;12(1)5960.
16.) Kahn S, Trow TK. “Best peep therapy in the injured lung”. Clin Pulm Med, January 2005;12(1):56-57.
17.) Trow TK. “COPD: big trouble in the small airways.” Clin Pulm Med, November 2004; 11 (6):386-387.
18.) Ferreira GJ, Trow TK. “Confusion over delirium: does it predict death in the intensive care unit?” Clin
Pulm Med, November 2004; 11 (6):387-389.
19.) DeLeon DG, Trow TK “Live ‘free’ or die: total or free serum cortisol measure in the critically ill.”
Clin Pulm Med, September 2004; 11 (5):338-341.
20.) Trow TK. “Unmasking” the truth: the role of noninvasive mask ventilation in the intensive care unit.”
Clinical Pulmonary Medicine, September 2004; 11 (5)342-344.
21.) Gilleran S, Trow TK. “Factor V Leiden and the risk for thromboembolism: is anticoagulation the
answer?” Clin Pulm Med, July 2004; 11 (4): 264-265.
22.) Anderson J, Trow TK. “Ventilating the obese patient with acute lung injury: should the strategy be
different than that adopted for the patient of normal weight?” Clin Pulm Med, July 2004; 11 (4): 262-264.
21
23.) Ferreira G, Trow TK. “Chemotherapy after resection of non-small cell lung cancer: should it be
given?”Clin Pulm Med, May 2004; 11 (3): 191-192.
24.) Trow TK. “Shocking” results: blocking nitric oxide nonselectively. too much of a good thing?”
Clin Pulm Med, May 2004; 11 (3): 192-194.
25.) Weiss H, Trow TK. “A potentially better means of preventing recurrent venous thromboembolism is on
the horizon.” Clin Pulm Med, March 2004; 11 (2) 120-122.
26.) Mendez JL, Trow TK. “Transfusion-related lung injury: looking for the ‘evil humor’.” Clin Pulm
Med, March 2004; 11 (2) 122-124
27.) DeLeon DG, Trow TK.“Less ultrasound and less anticoagulation in the workup of deep-vein
thrombosis.”Clin Pulm Med, January 2004; 11 (1): 57-58.
28.) Liu J, Trow TK. “Sustained benefit of bosentan in pulmonary arterial hypertension: can that dog hunt?”
Clin Pulm Med, January 2004; 11 (1): 59.
29.) Anderson J, Trow TK.“Using noninvasive ventilation for patients who fail traditional weaning
techniques.” Clin Pulm Med, November 2003; 10 (6): 348-50.
30.) Gilleran S, Trow TK. “Macrolides and lung disease: more than an antibiotic?” Clin Pulm Med,
November 2003; 10 (6): 350-51.
31) Ferreira G,, Trow TK. “Warfarin loading: does it make sense?” Clin Pulm Med, September 2003; 10 (5):
295-96.
32.) Trow, TK. “Less is more – sometimes.” Clin Pulm Med, September 2003; 10 (5):299-301.
33.) Anderson J, Trow TK. “Prevention of recurrent venous thromboembolism with long-term, low-dose
warfarin therapy.” Clin Pulm Med, July 2003; 10 (4): 242-44.
34.) Gilleran S, Trow TK.“Long-term follow-up in survivors of acute respiratory distress.” Clin Pulm Med,
July 2003; 10 (4): 214-42.
35.) Trow TK.“Lung cancer screening: can we afford it?” Clin Pulm Med, May 2003; 10 (3): 188-89.
36.) Trow TK. “Non-small cell lung cancer: an update.” Winthrop-University Hospital Medical Journal
2002;24:296-297.
37) Arroliga AC, Trow TK. “Common paraneoplastic syndromes in patients with bronchogenic carcinoma”
Pulmonary and Critical Care Update, American College of Chest Physicians, 1996; 11:1-8.
38.) Trow TK.“Mechanisms of acute ventilatory muscle failure.” Resident & Staff Physician [Supplement],
October 1993; 17-24.
ABSTRACTS:
1.)Mathur A, Trow TK, Pisani M. “Risk factors for MICU admission in patients with pulmonary
hypertension”, ACCP Annual International Meeting, Vancouver, Candada, November, 2010.
2.) Li W, Bolin N, HendersonK, Pollack JS, Trow TK, Fahey J, White RI. “Reproducibility of oxygen
saturation monitoring during six-minute walk and exercise testing in patients with pulmonary arterial
venous malformations”, European Group for Pediatric Work Physiology and North American Society for
Pediatric Exercise Medicine Joint Scientific Conference, Niagra-on-the-Lake, Ontario, Canada, September
25th, 2010.
3.) Trow TK, Ragolia L, Hurewitz A, Ferreira G, Bartlett M. “Circulating levels of Prostaglandin D2
Synthase (PGDS) in Pulmonary Hypertension”, ACCP International Annual Meeting, Montreal, Canada,
Chest, October, 2005.
22
2) Ferreira G, Trow TK, Edelman M, Hurewitz A. “Histologic Analysis of Pulmonary Vasculature in a
Prostaglandin D2 Synthase Knockout Mouse Model”,ATS Annual Meeting, San Diego, CA, American
Journal of Respiratory and Critical Care Medicine, May 2004.
4) Kahir A, Seiber S, Gordon J, Trow TK. “Eosinophilic Lung Disease at a Community Hospital”. Belsky
Research Day. Danbury Hospital. Danbury, CT. May 3, 2000.
5) Moss M, Trow TK, Clardy N. “The response time for ICU pages is influenced by the type of paging
system”. ATS Annual Meeting. Chicago, IL. American Journal Respiratory & Critical Care, April 1998.
6) Maroto J, Trow TK, Seiber S, Nazer K. “Pulmonary microsporidiosis in a patient with acquired
immunodeficiency syndrome”. Connecticut Chapter. American College of Physicians Annual Research Day.
Trumball, CT. May 1995.
7) Russo A, Trow TK DeFrance.J, Seiber S. “Diffuse bronchiolitis obliterans organizing pneumonia
preceding the development of small cell carcinoma of the lung”. Connecticut Chapter. American College of
Physicians Annual Research Day. Trumball, CT. May 1995.
8) Perez JB, Bou-Khalil.P, Trow TK, Arroliga.A, Einarsson O, Clark T, Dann P, Burtis WJ. “A prospective
study of serum PTHrP levels in lung cancer.” American Journal Respiratory & Critical Care 1996; 153: (2):
A135.
9) Trow TK, Zheng T, Whiting N, Zitnik RJ, Merrill W, Ray P, Elias JA. “Cytokine regulation of human
lung fibroblast interleukin 11 production.” American Review Respiratory Disease 1993; 147: (2): A230.
MANUSCRIPTS IN PROGRESS:
“Adjunct Therapies and Calcium Channel Blockers”. In: ed Franz R, Klinger J, “Diagnosis and
Management of Pulmonary Hypertension”; Springer, New York, 2013.
2.) Taichman, D; Ornelas, J; Chung, L, Klinger, JL, Sandra Z, Mande J; Palevsky, Harold; Rich, St;
Sood, N, Trow, T, Yung, R, Elliott, CG, Badesch, D. “Pharmacologic Therapy for Pulmonary
Arterial Hypertension: CHEST Guideline. 2014, Chest, (accepted; in press)
1.)
RESEARCH STUDIES:
AEROGEN:
CHIRION:
A double-blind, placebo-controlled, parallel groupPhase 2
dose-ranging study of nebulized amikacin delivered via the
pulmonary drug delivery system (PDDS) in patients with
ventilator-associated pneumonia due to gram-negative
organisms. (09/04). Co-investigator.
A Phase 3, multicenter, randomized, placebo-controlled,
double-blind, three-arm study to evaluate the safety and
efficacy of Tifacogin (Recombinant tissue factor pathway
inhibitor) administration in subjects with severe
community-acquired pneumonia. (09/04). Co-investigator.
23
GENETECH:
An Epidemiological study of Xolair (Omalizumab):
Evaluating clinical effectiveness and long-term safety in
patients with moderate to severe asthma. (09/04). Coinvestigator.
MYOGEN INC.:
Ambrisentan in PAH – A Phase III, Randomized,
Double-Blind, Placebo-Controlled, Multicenter, Efficacy
Study of Ambrisentan in Subjects with Pulmonary Arterial
Hypertension. (05/04). Co-investigator.
ORGANON PHARMACEUTICAL:
THE VAN GOGH PE-STUDY (P64714), A multicenter,
international, randomized, open-label, assessor-blind,
non-inferiority study comparing the efficacy and safety of
once-weekly subcutaneous SANORG34006 with the
combination of (LMW) heparin and vitamin K antagonist
(VKA) in the treatment of acute symptomatic pulmonary
embolism. (12/03). Co-investigator
GLAXOSMITHKLINE :
An 18 – week randomized, double – blind, placebo controlled, multicenter study designed to compare
treatment with AIRFLO (cilomilast) to that with placebo
for changes in ventilatory mechanics and function (both at
rest and during exercise), as well as related exertional
dyspnea and exercise performance, in hyperinflated patients
with stable COPD. (11/03). Co-investigator.
A multicenter 3 year longitudinal prospective study to
identify novel endpoints and compare these with forced
expiratory volume in 1 second (FEV1) for their ability to
measure and predict COPD severity and its progression over
time (ECLIPSE TRIAL). (1/06). Co- Principle Investigator.
ASTRAZENECA PHARMACEUTICALS LP:
An 18-week randomized, double-blind, active-controlled,
parallel-group, single-dummy, multicenter, 12 week study
to assess the efficacy and safety of SYMBICORT pMDI
160/4.5 ug x 2 actuations once-daily (QD) compared to
SYMBICORT pMDI 80/4.5 ug x 2 actuations QD,
SYMBICORT pMDI 80/4.5 x 2 actuations twice-daily
(BID) and to budesonide pMDI 160 ug x 2 actuations QD in
asthmatic subjects 12 years of age and older. (10/03)
C.R. BARD, INC.:
A Multi-Center Clinical Trial of the Bard Silver-Coated
Endotracheal Tube to Reduce Ventilator Associated
Pneumonia (VAP). (10/03)
INVESTIGATOR INITIATED:
Circulating Prostaglandin D2 Synthase (PGDS) Levels in
24
Pulmonary Hypertension. (09/03). Principle investigator.
Pulmonary Vascular Histopathology in a Prostaglanding D2
Synthase Knock-out Mouse Model (09/03). Principle
Investigator.
A Retrospective Review of Pulmonary Hypertension in the
Medical Intensive Care Unit, (11/208- present)Principle
Investigator
Association Between Pulmonary Artery Pressure and
Pulmonary Function Variables in Patients being Evaluated
for Pulmonary Arterial Hypertension. (3/13-present); Sub PI
Comparison of Right Ventricular Pressures by
Echocardiography and Performance on the Six Minute
Walk Test in Patients with Suspected Pulmonary
Hypertension. (7/13- present); Co-investigator.
INVESTIGATOR INITIATED:
Do Levels of Exhaled Nitric Oxide Increase as Right
Ventricular Systolic Pressures Improve in Individuals
treated with Bosentan? (03/04)
EISAI MEDICAL RESEARCH INC.:
A Double-Blind, Placebo-Controlled, Study of E5564, A
Lipid A Antagonist, Administered by Twice Daily
Intravenous Infusions in Patients with Severe Sepsis.
(06/03). Co-investigator.
ACTELION PHARMECEUTICALS:
Effects of combination of bosentan and sildenafil versus
sildenafil monotherapy on morbidity and mortality in
symptomatic patients with pulmonary arterial hypertension
– a multicenter, double-blind, randomized, placebocontrolled, parallel group, prospective, event driven Phase
IV study. (COMPASS II). (1/06). Principle Investigator.
Ventavis Registry (RESPIRE). Registry to evaluate use of
Ventavis® in patients with pulmonary arterial hypertension.
(3/10). Principle investigator.
GILEAD OF COLORADO PHARMECEUTICALS:
“ARIES-3: A Phase III, long-term, open label, multicenter
safety and efficacy study of ambrisentan in subjects with
pulmonary hypertension. (1/07). Sub-Principle Investigator.
EKOS CORPORATION:
“Submassive and Massive Pulmonary Embolism Treatment
with Ultrasound Accelerated Thromobolyis Therapy. A
Prospective, Single-Arm, Multi-center Trial of EkoSonic
Endovascular System and Ativase for Acute Pulmonary
Embolism. (SEATTLE Trial). (8/12). Co-investigator.
NATIONAL INSTITUES OF HEALTH:
“A Randomized, Double-blind, Placebo-Controlled, Phase
II Mulit-center Trial of a Monoclonal Antibody to CD20
25
(Rituximab) for the Treatment of Systemic SclerosisAssociated Pulmonary Arterial Hypertension (SSc-PAH).
(9/12). Sub-investigator.
INDEPENDENT INVESTIGATOR STUDIES:
“A Retrospective Review of Pulmonary Hypertension in the
Intensive Care Unit”. (11/09). Principle Investigator.
“Reproducibility of Exercise Stress Testing (EST} and 6Minute Walk Test (6MWT} for Detection of Right-to-Left
Shunting in Patients with Focal Pulmonary Arteriovenous
Malformations”. Co-Investigator.
AMERICAN COLLEGE OF CHEST
PHYSICIANS:
“Venous Thromboembolism Prophylaxis Performance
Improvement Project (VTE-PIPP). AQuIRE (The ACCP
Quality Improvement Regsitry. (7/11). Co-investigator.